Virtu Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Virtu Financial’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,815	Closed	-$700K	–	1588
2025 Q3	$700K	Buy	+32,815	New	+$776K	0.04%	442
2024 Q3	–	Sell	-14,712	Closed	-$239K	–	1307
2024 Q2	$239K	Sell	14,712 -700	-5%	-$11.3K	0.02%	654
2024 Q1	$285K	Buy	+15,412	New	+$382K	0.02%	633
2022 Q3	–	Sell	-15,354	Closed	-$216K	–	1666
2022 Q2	$216K	Buy	+15,354	New	+$287K	0.02%	730
2022 Q1	–	Sell	-44,980	Closed	-$1.05M	–	1440
2021 Q4	$1.05M	Buy	+44,980	New	+$905K	0.11%	182
2021 Q3	–	Sell	-47,189	Closed	-$1.15M	–	1440
2021 Q2	$1.15M	Buy	+47,189	New	+$1.07M	0.11%	166
2020 Q3	–	Sell	-12,285	Closed	-$595K	–	988
2020 Q2	$595K	Buy	+12,285	New	+$590K	0.07%	315
2019 Q4	$881K	Sell	20,601 -25,513	-55%	-$1.11M	0.09%	257
2019 Q3	$1.66M	Buy	+46,114	New	+$1.4M	0.13%	148
2019 Q2	–	Sell	-18,727	Closed	-$503K	–	1416
2019 Q1	$503K	Sell	18,727 -4,248	-18%	-$99.2K	0.03%	557
2018 Q4	$372K	Buy	+22,975	New	+$446K	0.02%	623

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Virtu Financial's ACAD Position: Q4 2025 in Review

Virtu Financial sold out of Acadia Pharmaceuticals (ACAD) in Q4 2025, closing a stake of 32,815 shares — an estimated $700K sold.

Virtu Financial first reported a position in ACAD in Q4 2018 and held it in 11 quarters. The position peaked at $1.66M in Q3 2019. 336 funds tracked by Wall St. Rank hold ACAD as of Q4 2025.

Virtu Financial reported no remaining Acadia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 32,815 Acadia Pharmaceuticals shares in Q4 2025, an estimated $700K.
Virtu Financial first reported a position in Acadia Pharmaceuticals in Q4 2018 and held it in 11 quarters.
Virtu Financial's Acadia Pharmaceuticals position peaked at $1.66M in Q3 2019.
336 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.